Sat.Mar 11, 2023

article thumbnail

Covering new weight loss drugs could strain Medicare, policy experts warn

STAT

The emergence of highly effective obesity drugs has spurred renewed efforts to get Medicare to pay for weight loss medications, but a group of health policy experts is sounding caution. Even a small amount of uptake would create significant costs for Medicare, likely leading the federal insurer to raise premiums in the long run, the researchers said in a perspective piece Saturday in the New England Journal of Medicine.

article thumbnail

Revealed: experts who praised new ‘skinny jab’ received payments from drug maker

The Guardian - Pharmaceutical Industry

Observer investigation finds Novo Nordisk gave millions to obesity charities and healthcare professionals, including expert who advised Nice ‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate The drug giant behind weight loss injections newly approved for NHS use spent millions in just three years on an “orchestrated PR campaign” to boost its UK influence.

76
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: FDA approves first treatment for Rett syndrome, a genetic neurological disease

STAT

The Food and Drug Administration on Friday approved the first treatment for Rett syndrome, a genetic disease mostly affecting girls that causes severe neurologic impairments, robbing them of the ability to communicate or control muscle movement. The new drug, called Daybue, is made by Acadia Pharmaceuticals. It’s not a cure, but in a clinical trial, the drug improved behavioral symptoms associated with Rett.

article thumbnail

Explainer: New skinny jab has been approved by the NHS - but does it work and can you buy it?

The Guardian - Pharmaceutical Industry

Websites appear to be defying a UK ban on advertising prescription drugs by urging customers to register their interest in the new weight-loss injection As controversy raged about the new weight loss drug approved for use on the NHS , retail chain Superdrug was last week urging customers to register interest in the injection. Though advertising prescription drugs is in theory banned, the online ad reflected public enthusiasm for what is widely called a wonder drug.

75
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How much is Pylera without insurance?

The Checkup by Singlecare

Is Pylera covered by insurance? | How much does Pylera cost without insurance? | How to get Pylera without insurance Pylera is a brand-name prescription drug that is FDA-approved to eradicate Helicobacter pylori infections in people with duodenal ulcers. H. pylori is a bacterium that infects the stomach lining. Over time, the infection can damage the stomach lining and the first part of the small intestine, the duodenum.

article thumbnail

‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate

The Guardian - Pharmaceutical Industry

Maker of Wegovy, an appetite suppressor hailed as a weight-loss magic bullet, has given millions to health organisations and experts, including payments to some of its biggest cheerleaders Revealed: experts who praised new ‘skinny jab’ received payments from drug maker During a prime-time breakfast slot on BBC Radio 4 last week, a leading obesity expert sang the praises of a blockbuster new weight-loss treatment.

72